Doctors of USF Health - USF Health - Tampa Physicians / Doctors

Richard Lockey , MD

Specialities: Allergy & Immunology

Spoken Languages : English

Primary Address

Phone

() -

Fax

() -

Administrative Appointment
Division Chief

Primary Department
COLLEGE OF MEDICINE INTERNAL MEDICINE

Distinguished Professor
COLLEGE OF MEDICINE INTERNAL MEDICINE

Distinguished Professor
COLLEGE OF MEDICINE PEDIATRICS

Health Care philosophy

I believe that all individuals should receive cost-effective medicine, i.e., that obtaining a detailed and appropriate history is the most important part of the phsyician's encounter with the patient. The physical examination is next important and laboratory studies have to be appropriate for the differential diagnosis and be ordered in the most cost-effective manner. Medical care in the United States is the best in the world; however, it has to be practiced in a very cost-effective manner.

Clinical Interests

Asthma, allergy and immunology.

Outside Interests

Hunting and fishing, collecting and refurbishing antique tools, supporting the Performing Arts, classical music and art.

Family

Wife and two children.

Other Addresses

USF Academic Address , 13000 Bruce B. Downs Blvd. , 111D Tampa, FL 33612
Mail Point , MDC Box 19 ,

Education

MS, Medicine, University of Michigan, Ann Arbor, MI - 1972
Allergy & Immunology, University of Michigan, Ann Arbor, MI - 1970
MS, Medicine, University of Michigan, Ann Arbor, MI - 1970
Medicine, University of Michigan, Ann Arbor, MI - 1968
Medicine, Temple University School of Med., Philadelphia, PA - 1966
MD, Temple University School of Medicine, Philadelphia, PA - 1965
MD, Medicine, Temple University School of Medicine, Haverford, PA - 1965
BS, Haverford College, Haverford, PA - 1961
BS, Biology, Haverford College, Haverford, PA - 1961

Selected Publications

Butt, A.Rashid, D.Lockey, RF. Do hypoallergenic cats and dogs exist? Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 108(2): 74-6, 2012.
Lötvall, J.Pawankar, R.Wallace, DV.Akdis, CA.Rosenwasser, LJ.Weber, RW.Wesley Burks, A.Casale, TB.Lockey, RF.Papadopoulos, NG.Fineman, SM.Ledford, DK. We call for iCAALL: International Collaboration in Asthma, Allergy and Immunology. Allergy. 67(4): 449-50, 2012.
Kolliputi, N.Galam, L.Parthasarathy, PT.Tipparaju, SM.Lockey, RF. NALP-3 inflammasome silencing attenuates ceramide-induced transepithelial permeability. Journal of cellular physiology. 227(9): 3310-6, 2012.
Pawankar, R.Canonica, GW.Holgate, ST.Lockey, RF. Allergic diseases and asthma: a major global health concern. Current opinion in allergy and clinical immunology. 12(1): 39-41, 2012.
Lötvall, J.Pawankar, R.Wallace, DV.Akdis, CA.Rosenwasser, LJ.Weber, RW.Burks, AW.Casale, TB.Lockey, RF.Papadopoulos, NG.Fineman, SM.Ledford, DK. We call for iCAALL: International Collaboration in Asthma, Allergy and Immunology. The Journal of allergy and clinical immunology. 129(4): 904-5, 2012.
Lötvall, J.Pawankar, R.Wallace, DV.Akdis, CA.Rosenwasser, LJ.Weber, RW.Burks, AW.Casale, TB.Lockey, RF.Papadopoulos, NG.Fineman, SM.Ledford, DK. We call for iCAALL: International Collaboration for Asthma, Allergy and Immunology. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 108(4): 215-6, 2012.
Simons, FE.Ardusso, LR.Bilò, MB.Dimov, V.Ebisawa, M.El-Gamal, YM.Ledford, DK.Lockey, RF.Ring, J.Sanchez-Borges, M.Senna, GE.Sheikh, A.Thong, BY.Worm, M. 2012 Update: World Allergy Organization Guidelines for the assessment and management of anaphylaxis. Current opinion in allergy and clinical immunology. 12(4): 389-399, 2012.
Lockey, RF.Hankin, CS. Health economics of allergen-specific immunotherapy in the United States. The Journal of allergy and clinical immunology. 127(1): 39-43, 2011.
Hankin, CS.Lockey, RF. Patient characteristics associated with allergen immunotherapy initiation and adherence. The Journal of allergy and clinical immunology. 127(1): 46-8, 48.e1-3, 2011.
Hankin, CS.Lockey, RF. Patient characteristics associated with allergen immunotherapy initiation and adherence. The Journal of allergy and clinical immunology. 127(1): 46-8, 48.e1-3, 2011.
Lockey, RF.Hankin, CS. Health economics of allergen-specific immunotherapy in the United States. The Journal of allergy and clinical immunology. 127(1): 39-43, 2011.
Zhang, W.Cao, X.Chen, D.Wang, JW.Yang, H.Wang, W.Mohapatra, S.Hellermann, G.Kong, X.Lockey, RF.Mohapatra, SS. Plasmid-encoded NP73-102 modulates atrial natriuretic peptide receptor signaling and plays a critical role in inducing tolerogenic dendritic cells. Genetic vaccines and therapy. 9(1): 3, 2011.
Fitzhugh, DJ.Lockey, RF. History of immunotherapy: the first 100 years. Immunology and allergy clinics of North America. 31(2): 149-57, vii, 2011.
Phillips, JF.Lockey, RF.Fox, RW.Ledford, DK.Glaum, MC. Systemic reactions to subcutaneous allergen immunotherapy and the response to epinephrine. Allergy and asthma proceedings : the official journal of regional and state allergy societies. 32(4): 288-94, 2011.
Fitzhugh, DJ.Lockey, RF. Allergen immunotherapy: a history of the first 100 years. Current opinion in allergy and clinical immunology. 11(6): 554-9, 2011.
Kumar, A.Jena, PK.Behera, S.Lockey, RF.Mohapatra, S.Mohapatra, S. Multifunctional magnetic nanoparticles for targeted delivery. Nanomedicine : nanotechnology, biology, and medicine. 6(1): 64-9, 2010.
Cox, L.Larenas-Linnemann, D.Lockey, RF.Passalacqua, G. Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System. The Journal of allergy and clinical immunology. 125(3): 569-74, 574.e1-574.e7, 2010.
Fiocchi, A.Schünemann, HJ.Brozek, J.Restani, P.Beyer, K.Troncone, R.Martelli, A.Terracciano, L.Bahna, SL.Rancé, F.Ebisawa, M.Heine, RG.Assa'ad, A.Sampson, H.Verduci, E.Bouygue, GR.Baena-Cagnani, C.Canonica, W.Lockey, RF. Diagnosis and Rationale for Action Against Cow's Milk Allergy (DRACMA): a summary report. The Journal of allergy and clinical immunology. 126(6): 1119-28.e12, 2010.
Phillips, JF.Jelks, ML.Lockey, RF. Important Florida botanical aeroallergens. Allergy and asthma proceedings : the official journal of regional and state allergy societies. 31(4): 337-40, 2010.
Fiocchi, A.Schünemann, HJ.Brozek, J.Restani, P.Beyer, K.Troncone, R.Martelli, A.Terracciano, L.Bahna, SL.Rancé, F.Ebisawa, M.Heine, RG.Assa'ad, A.Sampson, H.Verduci, E.Bouygue, GR.Baena-Cagnani, C.Canonica, W.Lockey, RF. Diagnosis and Rationale for Action Against Cow's Milk Allergy (DRACMA): a summary report. The Journal of allergy and clinical immunology. 126(6): 1119-28.e12, 2010.
Cox, L.Larenas-Linnemann, D.Lockey, RF.Passalacqua, G. Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System. The Journal of allergy and clinical immunology. 125(3): 569-74, 574.e1-574.e7, 2010.
Phillips, JF.Jelks, ML.Lockey, RF. Important Florida botanical aeroallergens. Allergy and asthma proceedings : the official journal of regional and state allergy societies. 31(4): 337-40, 2010.
Kumar, A.Jena, PK.Behera, S.Lockey, RF.Mohapatra, S.Mohapatra, S. Multifunctional magnetic nanoparticles for targeted delivery. Nanomedicine : nanotechnology, biology, and medicine. 6(1): 64-9, 2010.
Phillips, JF.Lockey, RF. Exotic pet allergy. The Journal of allergy and clinical immunology. 123(2): 513-5, 2009.
Wang, X.Xu, W.Kong, X.Chen, D.Hellermann, G.Ahlert, TA.Giaimo, JD.Cormier, SA.Li, X.Lockey, RF.Mohapatra, S.Mohapatra, SS. Modulation of lung inflammation by vessel dilator in a mouse model of allergic asthma. Respiratory research. 10(): 66, 2009.
Murray, JJ.Weiler, JM.Schwartz, LB.Busse, WW.Katial, RK.Lockey, RF.McFadden, ER.Pixton, GC.Barrett, RJ. Safety of binodenoson, a selective adenosine A2A receptor agonist vasodilator pharmacological stress agent, in healthy subjects with mild intermittent asthma. Circulation. Cardiovascular imaging. 2(6): 492-8, 2009.
Canonica, GW.Bousquet, J.Casale, T.Lockey, RF.Baena-Cagnani, CE.Pawankar, R.Potter, PC.Bousquet, PJ.Cox, LS.Durham, SR.Nelson, HS.Passalacqua, G.Ryan, DP.Brozek, JL.Compalati, E.Dahl, R.Delgado, L.van Wijk, RG.Gower, RG.Ledford, DK.Filho, NR.Valovirta, EJ.Yusuf, OM.Zuberbier, T.Akhanda, W.Almarales, RC.Ansotegui, I.Bonifazi, F.Ceuppens, J.Chivato, T.Dimova, D.Dumitrascu, D.Fontana, L.Katelaris, CH.Kaulsay, R.Kuna, P.Larenas-Linnemann, D.Manoussakis, M.Nekam, K.Nunes, C.O'Hehir, R.Olaguibel, JM.Onder, NB.Park, JW.Priftanji, A.Puy, R.Sarmiento, L.Scadding, G.Schmid-Grendelmeier, P.Seberova, E.Sepiashvili, R.Solé, D.Togias, A.Tomino, C.Toskala, E.Van Beever, H.Vieths, S. Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009. Allergy. 64 Suppl 91(): 1-59, 2009.
Casale, TB.Canonica, GW.Bousquet, J.Cox, L.Lockey, R.Nelson, HS.Passalacqua, G. Recommendations for appropriate sublingual immunotherapy clinical trials. The Journal of allergy and clinical immunology. 124(4): 665-70, 2009.
Murray, JJ.Weiler, JM.Schwartz, LB.Busse, WW.Katial, RK.Lockey, RF.McFadden, ER.Pixton, GC.Barrett, RJ. Safety of binodenoson, a selective adenosine A2A receptor agonist vasodilator pharmacological stress agent, in healthy subjects with mild intermittent asthma. Circulation. Cardiovascular imaging. 2(6): 492-8, 2009.
Kim D, Glaum M, Lockey RF Evaluation of combination long-acting ²-2 agonists and inhaled glucocorticosteroids for treatment of asthma Expert Opin Drug Metab Toxicology. 5(8): 93-40, 2009.
Bagg A, Chacko T, Lockey RF Reactions to prick and intradermal skin tests Annals of Allergy, Asthma & Immunology . 102(5): 400-2, 2009.
Wang X, Xu W, Kong X, Chen D, Hellermann G, Ahlert T, Giaimo J, Cormier S, Li X, Lockey RF, Mohapatra S, Mohapatra SS Modulation of lung inflammation by vessel dilator in a mouse model of allergic asthma Respiratory Research. 10(): 66, 2009.
Codina R, Fox RW, Lockey RF, DeMarco P, Bagg AS Typical levels of airborne fungal spores in houses without obvious moisture problems during a rainy season in Florida J Investig Allergol Clin Immunol . 18(3): 156-62, 2008.
Esch RE, Bush RK, Peden D, Lockey RF Sublingual-oral administration of standardized allergenic extracts: phase 1 safety and dosing results Ann Allergy Asthma Immunol . 100(5): 475-81, 2008.
Karpel J, DUrzo A, Lockey RF Inhaled mometasone furoate improves health-related quality of life in patients with persistent asthma Journal of Asthma. 45(): 747-753, 2008.
Windom, HH.Lockey, RF. An update on the safety of specific immunotherapy. Current opinion in allergy and clinical immunology. 8(6): 571-6, 2008.
Karpel, J.D'urzo, A.Lockey, RF. Inhaled mometasone furoate improves health-related quality of life in patients with persistent asthma. The Journal of asthma : official journal of the Association for the Care of Asthma. 45(9): 747-53, 2008.
Cox, L.Lockey, RF. Instructions and consent forms for subcutaneous allergen immunotherapy. Clinical allergy and immunology. 21(): 499-525, 2008.
Bukantz, SC.Bagg, AS.Lockey, RF. Adverse effects and fatalities associated with subcutaneous allergen immunotherapy. Clinical allergy and immunology. 21(): 455-68, 2008.
Müller, U.Golden, DB.Lockey, RF.Shin, B. Immunotherapy for hymenoptera venom hypersensitivity. Clinical allergy and immunology. 21(): 377-92, 2008.
Fernández-Caldas, E.Puerta, L.Caraballo, L.Lockey, RF. Mite allergens. Clinical allergy and immunology. 21(): 161-82, 2008.
Mohapatra, SS.Lockey, RF.Polo, F. Weed pollen allergens. Clinical allergy and immunology. 21(): 127-39, 2008.
Lockey, RF.Ledford, DK. Allergens and allergen immunotherapy. Preface. Clinical allergy and immunology. 21(): vii, 2008.
Cagnani, CE.Lockey, RF.Passalacqua, G.Canonica, GW. [Immunotherapy in Latin America. From the past to the future]. Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993). 55(1): 33-7, 2008.
King, MJ.Tamulis, T.Lockey, RF. Prick puncture skin tests and serum specific IgE as predictors of nasal challenge response to dermatophagoides pteronyssinus in older adults. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 101(1): 12-7, 2008.
Varghese, M.Lockey, RF. Aspirin-exacerbated asthma. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology. 4(2): 75-83, 2008.
Esch, RE.Bush, RK.Peden, D.Lockey, RF. Sublingual-oral administration of standardized allergenic extracts: phase 1 safety and dosing results. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 100(5): 475-81, 2008.
Wang, X.Xu, W.Mohapatra, S.Kong, X.Li, X.Lockey, RF.Mohapatra, SS. Prevention of airway inflammation with topical cream containing imiquimod and small interfering RNA for natriuretic peptide receptor. Genetic vaccines and therapy. 6(): 7, 2008.
Kong, X.Wang, X.Xu, W.Behera, S.Hellermann, G.Kumar, A.Lockey, RF.Mohapatra, S.Mohapatra, SS. Natriuretic peptide receptor a as a novel anticancer target. Cancer research. 68(1): 249-56, 2008.
Lee, D.Zhang, W.Shirley, SA.Kong, X.Hellermann, GR.Lockey, RF.Mohapatra, SS. Thiolated chitosan/DNA nanocomplexes exhibit enhanced and sustained gene delivery. Pharmaceutical research. 24(1): 157-67, 2007.
Cole, SL.Ledford, DK.Lockey, RF.Daas, A.Kooper, J. Primary gastrointestinal lymphangiectasia presenting as cryptococcal meningitis. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 98(5): 490-2, 2007.
Kumar, A.Sahoo, B.Montpetit, A.Behera, S.Lockey, RF.Mohapatra, SS. Development of hyaluronic acid-Fe2O3 hybrid magnetic nanoparticles for targeted delivery of peptides. Nanomedicine : nanotechnology, biology, and medicine. 3(2): 132-7, 2007.
Powell, SA.Nguyen, CT.Gaziano, J.Lewis, V.Lockey, RF.Padhya, TA. Mass psychogenic illness presenting as acute stridor in an adolescent female cohort. The Annals of otology, rhinology, and laryngology. 116(7): 525-31, 2007.
Lupoli, TA.Lockey, RF. Temporomandibular dysfunction: an often overlooked cause of chronic headaches. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 99(4): 314-8, 2007.
Cole, SL.Ledford, DK.Lockey, RF.Daas, A.Kooper, J. Primary gastrointestinal lymphangiectasia presenting as cryptococcal meningitis. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 98(5): 490-2, 2007.
Powell SA, Nguyen CT, Gaziano J, Lewis V, Lockey RF, Padhya TA Mass psychogenic illness presenting as acute stridor in an adolescent female cohort Annals of Otology, Rhinology & Laryngology . 7(116): 525-31, 2007.
Sahoo B, Kumar A, Montpetit A, Behera S, Lockey RF, Mohapatra SS Development of hyaluronic acid-Fe2O3 hybrid magnetic nanoparticles for targeted delivery of peptides Nanomedicine: Nanotechnology, Biology, and Medicin. 3(2): 132-7, 2007.
Kong, X.Zhang, W.Lockey, RF.Auais, A.Piedimonte, G.Mohapatra, SS. Respiratory syncytial virus infection in Fischer 344 rats is attenuated by short interfering RNA against the RSV-NS1 gene. Genetic vaccines and therapy. 5(): 4, 2007.
Codina, R.Lockey, RF. Indoor allergen assessments: a call for universal standards. The Journal of allergy and clinical immunology. 119(2): 518, 2007.
Passalacqua, G.Bousquet, PJ.Carlsen, KH.Kemp, J.Lockey, RF.Niggemann, B.Pawankar, R.Price, D.Bousquet, J. ARIA update: I--Systematic review of complementary and alternative medicine for rhinitis and asthma. The Journal of allergy and clinical immunology. 117(5): 1054-62, 2006.
Lieberman, PL.Kaliner, MA.Lockey, RF.Simons, FE. The allergy archives: pioneers and milestones. The Journal of allergy and clinical immunology. 117(2): 478-82, 2006.
Lee, DW.Shirley, SA.Lockey, RF.Mohapatra, SS. Thiolated chitosan nanoparticles enhance anti-inflammatory effects of intranasally delivered theophylline. Respiratory research. 7(): 112, 2006.
Ramey, JT.Lockey, RF. Allergic and nonallergic reactions to nitroglycerin. Allergy and asthma proceedings : the official journal of regional and state allergy societies. 27(3): 273-80, 2006.
Zhang, W.Lockey, RF.Mohapatra, SS. Respiratory syncytial virus: immunopathology and control. Expert review of clinical immunology. 2(1): 169-79, 2006.
Kearney, DM.Lockey, RF. Osteoporosis and asthma. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 96(6): 769-74; quiz 775-8, 857, 2006.
Singam, R.Jena, PK.Behera, S.Hellermann, GR.Lockey, RF.Ledford, D.Mohapatra, SS. Combined fluticasone propionate and salmeterol reduces RSV infection more effectively than either of them alone in allergen-sensitized mice. Virology journal. 3(): 32, 2006.
Lockey, RF. Rhinitis medicamentosa and the stuffy nose. The Journal of allergy and clinical immunology. 118(5): 1017-8, 2006.
Zhang, W.Yang, H.Kong, X.Mohapatra, S.San Juan-Vergara, H.Hellermann, G.Behera, S.Singam, R.Lockey, RF.Mohapatra, SS. Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene. Nature medicine. 11(1): 56-62, 2005.
Mohapatra, SS.Lockey, RF.Shirley, S. Immunobiology of grass pollen allergens. Current allergy and asthma reports. 5(5): 381-7, 2005.
Demarco, PJ.Lockey, RF. Outcomes of allergy to insect stings in children, with and without venom immunotherapy. The Journal of pediatrics. 146(1): 145-6, 2005.
Kong, X.Hellermann, GR.Patton, G.Kumar, M.Behera, A.Randall, TS.Zhang, J.Lockey, RF.Mohapatra, SS. An immunocompromised BALB/c mouse model for respiratory syncytial virus infection. Virology journal. 2(): 3, 2005.
King, MJ.Bukantz, SC.Phillips, S.Mohapatra, SS.Tamulis, T.Lockey, RF. Serum total IgE and specific IgE to Dermatophagoides pteronyssinus, but not eosinophil cationic protein, are more likely to be elevated in elderly asthmatic patients. Allergy and asthma proceedings : the official journal of regional and state allergy societies. 25(5): 321-5, 2004.
Ravi Kumar, M.Hellermann, G.Lockey, RF.Mohapatra, SS. Nanoparticle-mediated gene delivery: state of the art. Expert opinion on biological therapy. 4(8): 1213-24, 2004.
Hellermann, G.Kong, X.Gunnarsdóttir, J.San Juan, H.Singam, R.Behera, S.Zhang, W.Lockey, RF.Mohapatra, SS. Mechanism of bronchoprotective effects of a novel natriuretic hormone peptide. The Journal of allergy and clinical immunology. 113(1): 79-85, 2004.
Kong, X.San Juan, H.Behera, A.Peeples, ME.Wu, J.Lockey, RF.Mohapatra, SS. ERK-1/2 activity is required for efficient RSV infection. FEBS letters. 559(1-3): 33-8, 2004.
Mohapatra, SS.Lockey, RF.Polo, F. Weed pollen allergens. Clinical allergy and immunology. 18(): 207-22, 2004.
Fernández-Caldas, E.Puerta, L.Caraballo, L.Lockey, RF. Mite allergens. Clinical allergy and immunology. 18(): 251-70, 2004.
Müller, UR.Golden, DB.Demarco, PJ.Lockey, RF. Immunotherapy for hymenoptera venom and biting insect hypersensitivity. Clinical allergy and immunology. 18(): 541-59, 2004.
Asher, I.Baena-Cagnani, C.Boner, A.Canonica, GW.Chuchalin, A.Custovic, A.Dagli, E.Haahtela, T.Haus, M.Lemmo-Hoten, M.Holgate, S.Holloway, J.Holt, P.Host, A.Iikura, Y.Johansson, SG.Kaplan, A.Kowalski, ML.Lockey, RF.Naspitz, C.Odhiambo, J.Ring, J.Sastre, J.Venables, K.Vichyanond, P.Volovitz, B.Wahn, U.Warner, J.Weiss, K.Zhong, NS. World Allergy Organization guidelines for prevention of allergy and allergic asthma. International archives of allergy and immunology. 135(1): 83-92, 2004.
Mohapatra, SS.Lockey, RF.Vesely, DL.Gower, WR. Natriuretic peptides and genesis of asthma: an emerging paradigm? The Journal of allergy and clinical immunology. 114(3): 520-6, 2004.
Zhang, W.Singam, R.Hellermann, G.Kong, X.Juan, HS.Lockey, RF.Wu, SJ.Porter, K.Mohapatra, SS. Attenuation of dengue virus infection by adeno-associated virus-mediated siRNA delivery. Genetic vaccines and therapy. 2(1): 8, 2004.
San-Juan-Vergara, H.Peeples, ME.Lockey, RF.Mohapatra, SS. Protein kinase C-alpha activity is required for respiratory syncytial virus fusion to human bronchial epithelial cells. Journal of virology. 78(24): 13717-26, 2004.
Cox, L.Lockey, RF. Instructions and consent forms for allergen immunotherapy. Clinical allergy and immunology. 18(): 755-84, 2004.
Johansson, SG.Bieber, T.Dahl, R.Friedmann, PS.Lanier, BQ.Lockey, RF.Motala, C.Ortega Martell, JA.Platts-Mills, TA.Ring, J.Thien, F.Van Cauwenberge, P.Williams, HC. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. The Journal of allergy and clinical immunology. 113(5): 832-6, 2004.
Bukantz, SC.Lockey, RF. Adverse effects and fatalities associated with subcutaneous allergen immunotherapy. Clinical allergy and immunology. 18(): 711-27, 2004.
Kuderer, NM.San-Juan-Vergara, HG.Kong, X.Esch, R.Lockey, RF.Mohapatra, SS. Mite and cockroach proteases activate p44/p42 MAP kinases in human lung epithelial cells. Clinical and molecular allergy : CMA. 1(1): 1, 2003.
King, MJ.Lockey, RF. Allergen prick-puncture skin testing in the elderly. Drugs & aging. 20(14): 1011-7, 2003.
Matsuse, H.Kong, X.Hu, J.Wolf, SF.Lockey, RF.Mohapatra, SS. Intranasal IL-12 produces discreet pulmonary and systemic effects on allergic inflammation and airway reactivity. International immunopharmacology. 3(4): 457-68, 2003.
Kumar, M.Kong, X.Behera, AK.Hellermann, GR.Lockey, RF.Mohapatra, SS. Chitosan IFN-gamma-pDNA Nanoparticle (CIN) Therapy for Allergic Asthma. Genetic vaccines and therapy. 1(1): 3, 2003.
Kong, X.San Juan, H.Kumar, M.Behera, AK.Mohapatra, A.Hellermann, GR.Mane, S.Lockey, RF.Mohapatra, SS. Respiratory syncytial virus infection activates STAT signaling in human epithelial cells. Biochemical and biophysical research communications. 306(2): 616-22, 2003.
Fox, RW.Lockey, RF. The impact of rhinosinusitis on asthma. Current allergy and asthma reports. 3(6): 513-8, 2003.
Kumar, M.Behera, AK.Lockey, RF.Zhang, J.Bhullar, G.De La Cruz, CP.Chen, LC.Leong, KW.Huang, SK.Mohapatra, SS. Intranasal gene transfer by chitosan-DNA nanospheres protects BALB/c mice against acute respiratory syncytial virus infection. Human gene therapy. 13(12): 1415-25, 2002.
Behera, AK.Kumar, M.Lockey, RF.Mohapatra, SS. Adenovirus-mediated interferon gamma gene therapy for allergic asthma: involvement of interleukin 12 and STAT4 signaling. Human gene therapy. 13(14): 1697-709, 2002.
Ramirez, NC.Lockey, RF. Nocturnal asthma. Strategies that put it to rest. Advance for nurse practitioners. 10(1): 75-8, 2002.
Stablein, JJ.Bucholtz, GA.Lockey, RF. Melaleuca tree and respiratory disease. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 89(5): 523-30, 2002.
Theodoropoulos, DS.Pecoraro, DL.Lockey, RF.Boyce, HW.Bukantz, SC. Visceral sensitivity in gastroesophageal reflux. Digestive diseases and sciences. 47(11): 2554-64, 2002.
Kumar, M.Behera, AK.Lockey, RF.Vesely, DL.Mohapatra, SS. Atrial natriuretic peptide gene transfer by means of intranasal administration attenuates airway reactivity in a mouse model of allergic sensitization. The Journal of allergy and clinical immunology. 110(6): 879-82, 2002.
Lockey, RF. How now, brown cow, vaccine or extract? Current allergy and asthma reports. 2(3): 181-2, 2002.
Behera, AK.Kumar, M.Lockey, RF.Mohapatra, SS. 2'-5' Oligoadenylate synthetase plays a critical role in interferon-gamma inhibition of respiratory syncytial virus infection of human epithelial cells. The Journal of biological chemistry. 277(28): 25601-8, 2002.
Meltzer, EO.Lockey, RF.Friedman, BF.Kalberg, C.Goode-Sellers, S.Srebro, S.Edwards, L.Rickard, K. Efficacy and safety of low-dose fluticasone propionate compared with montelukast for maintenance treatment of persistent asthma. Mayo Clinic proceedings. Mayo Clinic. 77(5): 437-45, 2002.
Kemp, SF.Lockey, RF. Anaphylaxis: a review of causes and mechanisms. The Journal of allergy and clinical immunology. 110(3): 341-8, 2002.
Hellermann, GR.Nagy, SB.Kong, X.Lockey, RF.Mohapatra, SS. Mechanism of cigarette smoke condensate-induced acute inflammatory response in human bronchial epithelial cells. Respiratory research. 3(): 22, 2002.

Positions Held

Professor (Pediatrics, University of South Florida and All Children's Hospital 1987 - Present )
Professor (Public Health, University of South Florida 1987 - Present )
Director (Allergy and Immunology, University of South Florida College of Medicine 1982 - Present )
Chief (Section of Allergy and Immunology, James A Haley Veterans Hospital 1982 - Present )
Joy McCann Culverhouse Chair in Allergy and Immunology (College of Medicine, University of South Florida 1997 - Present )
Professor of Medicine (College of Medicine, University of South Florida 1983 - Present )

Memberships

Association of Clinical Researchers and Educators (ACRE) (Member, 2009 - Present)
Society of Industry Leaders (SIL), network of Vista Research, a division of Standard & Poor (Member, 2006 - Present)
Florida Academy of Sciences (Member, 2005 - Present)
Sigma Çi, The Scientific Research Society, Tampa Bay (Active member, 2004 - Present)
The European Academy of Allergology and Clinical Immunology (EAACI) (Member, 1996 - Present)
The International Scientific Board Pharmacia Allergy Research (Member, 1992 - Present)
World Allergy Organization (WAO) (President-Elect, 2008 - 2009)
Asthma and Allergy Foundation of America (Vice President, Medical Affairs, 1995 - 1998)
American Board of Allergy and Immunology (Director, 1993 - 1998)
American Academy of Allergy and Immunology (President, 1992 - 1993)

Grants

PROTOCOL #DX-88/24 ($140,345.00, 05/24/2010-05/23/2020)
PROTOCOL #A7881013 ($1,680.00, 05/01/2010-05/01/2016)
PROTOCOL #A7881013 ($251,849.00, 05/01/2010-05/01/2016)
PROTOCOL#A6631033 ($10,000.00, 05/25/2012-05/24/2015)
PROTOCOL #DX-88/24 ($5,000.00, 04/01/2012-03/31/2015)
PROTOCOL#HGT-FIR-086 ($7,957.00, 12/01/2011-11/30/2014)
PROTOCOL#HGT-FIR-086 ($10,000.00, 12/01/2011-11/30/2014)
PROTOCOL #HZC113782 ($2,163.00, 10/14/2011-10/13/2014)
PROTOCOL #HZC113782 ($8,393.00, 10/14/2011-10/13/2014)
PROTOCOL #HZC113782 ($10,000.00, 10/14/2011-10/13/2014)
PROTOCOL #HZC113782 ($13,905.00, 10/14/2011-10/13/2014)
PROTOCOL #HZC113782 ($8,248.00, 10/14/2011-10/13/2014)
PROTOCOL # ACT11457 ($7,500.00, 07/21/2011-07/20/2014)
PROTOCOL # ACT11457 ($13,000.00, 07/21/2011-07/20/2014)
PROTOCOL # MI-CP186 ($3,671.00, 07/02/2009-07/01/2014)
PROTOCOL # MI-CP186 ($102,356.00, 07/02/2009-07/01/2014)
PROTOCOL # HGT-FIR-054 ($240,196.00, 06/18/2009-06/17/2014)
PROTOCOL # C1 1310 ($11,839.00, 02/22/2011-02/21/2014)
PROTOCOL # C1 1310 ($14,573.00, 02/22/2011-02/21/2014)
PROTOCOL # C1 1310 ($35,218.00, 02/22/2011-02/21/2014)
PROTOCOL # C1 1310 ($14,832.00, 02/22/2011-02/21/2014)
PROTOCOL # C1 1310 ($10,000.00, 02/22/2011-02/21/2014)
PROTOCOL # C1 1310 ($12,314.00, 02/22/2011-02/21/2014)
PROTOCOL #MI-CP220-D3250L00001 ($113,683.00, 11/11/2010-11/10/2013)
PROTOCOL #1184.15 ($370,180.00, 07/09/2008-07/08/2013)
STUDY OF ASTHMA AND NASAL STEROIDS (STAN) ($8,000.00, 07/01/2010-06/30/2013)
ASSOCIATION OF GENETIC MARKERS WITH ASTHMA ($9,375.00, 07/01/1999-06/30/2013)
ASSOCIATION OF GENETIC MARKERS WITH ASTHMA ($9,375.00, 07/01/1999-06/30/2013)
ASSOCIATION OF GENETIC MARKERS WITH ASTHMA ($37,500.00, 07/01/1999-06/30/2013)
PROTOCOL #MI CP143 ($25,152.00, 06/02/2008-06/01/2013)
PROTOCOL #MI CP143 ($248,378.00, 06/02/2008-06/01/2013)
PROTOCOL #PO5122-17 ($79,100.00, 03/28/2008-03/27/2013)
PROTOCOL#HZA106853 ($1,785.00, 11/08/2011-12/18/2012)
PROTOCOL#HZA106853 ($10,003.00, 11/08/2011-12/18/2012)
PROTOCOL#A6631029 ($1,810.00, 08/24/2011-11/04/2012)
PROTOCOL#A6631029 ($9,861.00, 08/24/2011-11/04/2012)
PROTOCOL#A6631029 ($6,500.00, 08/24/2011-11/04/2012)
PROTOCOL #PO4505-40 ($142,680.00, 07/02/2007-07/01/2012)
PROTOCOL #PO4505-40 ($411,140.00, 07/02/2007-07/01/2012)
SOYA-THE STUDY OF SOY ISOFLAVONES IN ASTHMA ($4,000.00, 07/01/2010-06/30/2012)
STUDY OF ASTHMA AND NASAL STEROIDS (STAN) ($16,250.00, 07/01/2010-06/30/2012)
SOYA-THE STUDY OF SOY ISOFLAVONES IN ASTHMA ($15,040.00, 07/01/2010-06/30/2012)
ASSOCIATION OF GENETIC MARKERS WITH ASTHMA ($37,500.00, 07/01/1999-06/30/2012)
PROTOCOL #SKY2028.3.004 ($5,670.00, 01/23/2007-01/22/2012)
PROTOCOL #SKY2028.3.004 ($62,905.00, 01/23/2007-01/22/2012)
PROTOCOL #SKY2028.3.004 ($108,848.00, 01/23/2007-01/22/2012)
PROTOCOL #SKY2028.3.004 ($93,312.00, 01/23/2007-01/22/2012)
PROTOCOL #P04230-14 ($250,750.00, 01/12/2007-01/11/2012)
PROTOCOL #P04230-14 ($22,916.00, 01/12/2007-01/11/2012)
PROTOCOL #P04230-14 ($113,180.00, 01/12/2007-01/11/2012)
PROTOCOL #XRG5029C/3503 ($6,774.00, 11/14/2006-11/13/2011)
PROTOCOL #XRG5029C/3503 ($60,540.00, 11/14/2006-11/13/2011)
PROTOCOL #BY217/M2-124 ($6,000.00, 09/07/2006-09/06/2011)
PROTOCOL #BY217/M2-124 ($214,160.00, 09/07/2006-09/06/2011)
SARCA-THE STUDY OF ACID REFLUX IN CHILDREN WITH ASTHMA ($4,000.00, 07/01/2010-06/30/2011)
PROTOCOL #FFR101782 ($177,472.00, 04/01/2008-04/22/2011)
PROTOCOL #DX-88/14 (EDEMA 3) ($133,190.00, 03/01/2006-02/28/2011)
PROTOCOL #CQAB419B2351 ($49,263.00, 05/27/2009-09/30/2010)
INTERVIEW STUDY TO EXPLORE THE CONTENT VALIDITY OF VISUAL ANALOGUE SCALES TO ASSESS SEVERITY OF HEREDITARY ANGIOEDEMA (HAE) IN ADULTS IN THE USA AND ITALY ($5,680.00, 09/28/2009-09/27/2010)
INTERVIEW STUDY TO EXPLORE THE CONTENT VALIDITY OF VISUAL ANALOGUE SCALES TO ASSESS SEVERITY OF HEREDITARY ANGIOEDEMA (HAE) IN ADULTS IN THE USA AND ITALY ($3,539.00, 09/28/2009-09/27/2010)
PROTOCOL #377 ($1,624.00, 04/24/2009-08/23/2010)
PROTOCOL #377 ($58,934.00, 04/24/2009-08/23/2010)
PROTOCOL #C1 1205-01 ($10,375.00, 08/09/2005-08/08/2010)
PROTOCOL #C1 1205-01 ($20,000.00, 08/09/2005-08/08/2010)
PROTOCOL #C1 1205-01 ($106,500.00, 08/09/2005-08/08/2010)
PROTOCOL #DX- 88/19 ($379,050.00, 07/12/2007-07/11/2010)
PROTOCOL #DX-88/20 ($96,850.00, 07/12/2007-07/11/2010)
PROTOCOL #DX- 88/19 ($103,000.00, 07/12/2007-07/11/2010)
PROTOCOL #DX-88/20 ($3,000.00, 07/12/2007-07/11/2010)
PROTOCOL #DX- 88/19 ($3,000.00, 07/12/2007-07/11/2010)
SARCA - STUDY OF ACID REFLUX IN CHILDHOOD ASTHMA ($13,200.00, 07/01/2007-06/30/2010)
SARCA - STUDY OF ACID REFLUX IN CHILDHOOD ASTHMA ($8,000.00, 07/01/2007-06/30/2010)
ASSOCIATION OF GENETIC MARKERS WITH ASTHMA ($96,950.00, 07/01/1999-06/30/2010)
ASSOCIATION OF GENETIC MARKERS WITH ASTHMA ($11,799.00, 07/01/1999-06/30/2010)
PROTOCOL #QAB149B 2349 ($58,529.00, 12/04/2008-05/31/2010)
PROTOCOL #007-10 ($22,090.00, 01/15/2009-05/14/2010)
PROTOCOL #V211-017-03 ($25,581.00, 08/06/2008-03/31/2010)
PROTOCOL #PGX-I-AP-003 ($4,500.00, 11/25/2009-12/31/2009)
PROTOCOL #PGX-I-AP-002 ($4,500.00, 11/25/2009-12/31/2009)
GREER LABS PROTOCOL #SLIT03-04 REV070704 ($22,000.00, 11/04/2004-11/03/2009)
PROTOCOL #ADC111891 ($72,496.00, 12/05/2008-09/04/2009)
SARCA - STUDY OF ACID REFLUX IN CHILDHOOD ASTHMA ($21,200.00, 07/01/2007-06/30/2009)
ASSOCIATION OF GENETIC MARKERS WITH ASTHMA ($78,694.00, 07/01/1999-06/30/2009)
PROTOCOL #007 ($4,696.00, 02/18/2008-06/08/2009)
REPEATED NASAL CHALLENGE IN SKIN PRICK NEGATIVE INTERDERMAL POSITIVE DUST MITE PATIENTS ($10,000.00, 05/11/2008-05/11/2009)
PROTOCOL #D5896C00022 ($248,000.00, 04/30/2007-04/29/2009)
PROTOCOL #ADA109057 ($113,387.00, 05/29/2007-04/14/2009)
PROTOCOL #ADA109057 ($5,827.00, 05/29/2007-04/14/2009)
PROTOCOL #ADA109057 ($120,446.00, 05/29/2007-04/14/2009)
PROTOCOL #009-01 ($107,592.00, 06/25/2008-02/24/2009)
PROTOCOL #QAB149B2335S ($2,750.00, 08/01/2007-12/31/2008)
PROTOCOL #QAB149B2335S ($127,891.00, 08/01/2007-12/31/2008)
PROTOCOL #Q3662G ($218,105.00, 06/26/2006-12/01/2008)
PROTOCOL #Q3662G ($2,055.00, 06/26/2006-12/01/2008)
PROTOCOL #Q3662G ($177,355.00, 06/26/2006-12/01/2008)
PROTOCOL #007 ($149,137.00, 02/18/2008-10/17/2008)
PROTOCOL #B2C111045 ($118,715.00, 04/01/2008-10/03/2008)
PROTOCOL #HAE3973G ($106,855.00, 01/04/2007-10/01/2008)
PROTOCOL #FFA109687 ($26,131.00, 03/11/2008-09/18/2008)
PROTOCOL #FFA109684 ($177,018.00, 03/11/2008-09/18/2008)
PROTOCOL #FFA109687 ($155,889.00, 03/11/2008-09/18/2008)
PROTOCOL #M05-757 ($3,000.00, 08/27/2007-08/26/2008)
PROTOCOL #MEE103219 ($112,929.00, 05/15/2007-07/17/2008)
SIMMONS PROFESSORSHIP IN ASTHMA RESEARCH ($90,923.00, 07/01/2004-06/30/2008)
SIMMONS PROFESSORSHIP IN ASTHMA RESEARCH ($45,000.00, 07/01/2004-06/30/2008)
PROJECT 3: STUDY OF ACID REFLUX AND ASTHMA (SARA) ($21,000.00, 07/01/2004-06/30/2008)
JOY MCCANN CULVERHOUSE ENDOWED CHAIR IN ALLERGY AND IMMUNOLOGY ($321,154.00, 07/01/2002-06/30/2008)
JOY MCCANN CULVERHOUSE ENDOWED CHAIR IN ALLERGY AND IMMUNOLOGY ($545,569.00, 07/01/2002-06/30/2008)
JOY MCCANN CULVERHOUSE ENDOWED CHAIR IN ALLERGY AND IMMUNOLOGY ($288,279.00, 07/01/2002-06/30/2008)
ASSOCIATION OF GENETIC MARKERS WITH ASTHMA ($75,447.00, 07/01/1999-06/30/2008)
PROTOCOL #FFA109685 ($500.00, 03/11/2008-04/09/2008)
GLAXOSMITHKLINE/PROTOCOL #SAM40065 ($50,000.00, 03/07/2003-03/06/2008)
GLAXOSMITHKLINE/PROTOCOL #SAM40065 ($109,000.00, 03/07/2003-03/06/2008)
PROTOCOL #ACC-05-01 ($1,000.00, 09/10/2007-12/31/2007)
DYAX CORP/PROTOCOL #DX-88/4 ($91,316.00, 12/20/2002-12/19/2007)
GLAXOSMITHKLINE/PROTOCOL #SAM40066 ($31,505.00, 10/15/2002-10/14/2007)
GLAXOSMITHKLINE/PROTOCOL #SAM40066 ($33,990.00, 10/15/2002-10/14/2007)
SFA1000062 ($106,260.00, 10/07/2004-10/06/2007)
PROTOCOL #SFA1000062 ($110,260.00, 10/07/2004-10/06/2007)
PROTOCOL #FFU105927 ($166,845.00, 08/28/2007-10/03/2007)
PROTOCOL #SCO40043 ($9,734.00, 09/24/2004-09/23/2007)
PROTOCOL SCO40043 ($107,320.00, 09/24/2004-09/23/2007)
SCHERING-PLOUGH/PROTOCOL #P01861-150 ($62,200.00, 09/23/2002-09/22/2007)
QUINTILES/AVENTIS - PROTOCOL #M016455M/3002 ($98,975.00, 08/27/2002-08/26/2007)
PROTOCOL #D5896 C00001 ($83,000.00, 07/26/2004-07/25/2007)
PROJECT 3: STUDY OF ACID REFLUX AND ASTHMA (SARA) ($6,750.00, 07/01/2004-06/30/2007)
JOY MCCANN CULVERHOUSE ENDOWED CHAIR IN ALLERGY AND IMMUNOLOGY ($411,350.00, 07/01/2002-06/30/2007)
ASSOCIATION OF GENETIC MARKERS WITH ASTHMA (($29,743.00), 07/01/1999-06/30/2007)
ASSOCIATION OF GENETIC MARKERS WITH ASTHMA ($60,000.00, 07/01/1999-06/30/2007)
ASSOCIATION OF GENETIC MARKERS WITH ASTHMA ($60,000.00, 07/01/1999-06/30/2007)
PROTOCOL #IGE025A US23 ($78,942.00, 11/28/2005-06/01/2007)
QUINTILES/AVENTIS - PROTOCOL #M016455P/3003 ($153,300.00, 04/15/2002-04/14/2007)
QUINTILES/AVENTIS PROTOCOL #M016455P-3001 ($160,742.00, 04/15/2002-04/14/2007)
PROTOCOL # DX-88/5, EDEMA2 ($47,687.00, 02/26/2004-02/25/2007)
PROTOCOL #BY217/M2-023 ($33,180.00, 02/15/2004-02/15/2007)
PROTOCOL #BY217/M2-023 ($88,668.00, 02/15/2004-02/15/2007)
GLAXOSMITHKLINE/FAP30010 ($1,500.00, 02/01/2002-01/31/2007)
GLAXOSMITHKLINE/FAP30010 ($34,399.00, 02/01/2002-01/31/2007)
PROTOCOL #QAB149 B2329 ($1,500.00, 01/11/2006-01/10/2007)
PROTOCOL #FFA100240 ($1,500.00, 06/30/2005-12/31/2006)
PROTOCOL #ADA103578 ($2,000.00, 11/23/2005-10/23/2006)
PROTOCOL #ADA103578 ($79,640.00, 11/23/2005-10/23/2006)
PROTOCOL #ADA103578 ($69,548.00, 11/23/2005-10/23/2006)
PROTOCOL #FFA20003 ($1,500.00, 06/30/2005-10/23/2006)
PROTOCOL # MRE0470-203 ($3,000.00, 10/01/2003-09/30/2006)
PROTOCOL #MRE0470-203 ($69,800.00, 10/01/2003-09/30/2006)
SINUSITIS AND RHINITIS STUDY ($13,725.00, 07/01/2005-06/30/2006)
SINUSITIS AND RHINITIS STUDY ($17,250.00, 07/01/2005-06/30/2006)
CIL103657 ($125,733.00, 11/29/2004-06/30/2006)
CTMS/GSK/PROTOCOL #CIL103657 ($125,733.00, 11/29/2004-06/30/2006)
PROJECT 3: STUDY OF ACID REFLUX AND ASTHMA (SARA) ($24,750.00, 07/01/2004-06/30/2006)
PROTOCOL # OPL104226 ($114,361.00, 10/26/2005-05/31/2006)
PROTOCOL #ADA103578 ($54,686.00, 11/23/2005-05/17/2006)
SCHERING-PLOUGH RESEARCH/PROTOCOL #P01978-12 ($5,388.00, 12/15/2000-12/15/2005)
SCHERING-PLOUGH RESEARCH/PROTOCOL #P01978-12 ($4,500.00, 12/15/2000-12/15/2005)
AVENTIS/PROTOCOL #M016455A/4122 ($54,025.00, 10/18/2001-10/17/2005)
AVENTIS/PROTOCOL #M016455A/4122 ($68,250.00, 10/18/2001-10/17/2005)
SIMMONS PROFESSORSHIP IN ASTHMA RESEARCH ($115,000.00, 07/01/2004-06/30/2005)
SIMMONS PROFESSORSHIP IN ASTHMA RESEARCH ($65,000.00, 07/01/2004-06/30/2005)
PROJECT 3: STUDY OF ACID REFLUX AND ASTHMA (SARA) ($30,000.00, 07/01/2004-06/30/2005)
GLAXOSMITHKLINE/PROTOCOL #FFR100010 ($44,903.00, 01/17/2005-06/26/2005)
PROTOCOL #QAB0149B2205 ($103,070.00, 05/01/2004-06/01/2005)
GLAXOSMITHKLINE/PROTOCOL #FFR30002 ($97,054.00, 12/14/2004-04/14/2005)
GENENTECH PROTOCOL Q2196N "TENOR" ($6,192.00, 10/01/2000-12/31/2004)
GENENTECH PROTOCOL Q2196N "TENOR" ($22,900.00, 10/01/2000-09/30/2004)
GENENTECH PROTOCOL Q2196N "TENOR" ($2,415.00, 10/01/2000-07/30/2004)
PROJECT 2 - TRIAL OF ASTHMA PATIENT EDUCATION (TAPE) ($16,000.00, 07/01/2003-06/30/2004)
PROJECT 1 - LEUKOTRIENE MODIFIER OR CORTICOSTEROIDS TRIAL (LOCCS) ($63,450.00, 07/01/2003-06/30/2004)
ASSOCIATION OF GENETIC MARKERS WITH ASTHMA ($62,500.00, 07/01/1999-06/30/2004)
ASSOCIATION OF GENETIC MARKERS WITH ASTHMA ($75,000.00, 07/01/1999-06/30/2004)
ASSOCIATION OF GENETIC MARKERS WITH ASTHMA ($66,950.00, 07/01/1999-06/30/2004)
MILLENIUM/PROTOCOL #M97700-023 ($8,999.00, 06/06/2001-06/05/2004)
MILLENNIUM/PROTOCOL #M97700-023 ($70,999.00, 06/06/2001-06/05/2004)
WHITEHALL ROBINS/PROTOCOL # AD-99-02 ($1,135.00, 03/15/2001-03/14/2004)
WHITEHALL ROBINS/PROTOCOL # AD-99-02 ($5,340.00, 03/15/2001-03/14/2004)
WHITEHALL ROBINS/PROTOCOL # AD-99-02 ($30,600.00, 03/15/2001-03/14/2004)
PROTOCOL: FLTA 4038/4039 ($3,523.00, 09/14/1998-12/31/2003)
CLINTRIALS RESEARCH/SEPRACTOR PROTOCOL 051-915 ($10,128.00, 11/20/2000-11/19/2003)
CLINTRIALS RESEARCH/SEPRACTOR PROTOCOL 051-915 ($29,484.00, 11/20/2000-11/19/2003)
CLINTRIALS RESEARCH/SEPRACTOR PROTOCOL 051-915 ($42,552.00, 11/20/2000-11/19/2003)
FOREST LABORATORIES, INC./PROTOCOL #ANC-MD-17 ($2,400.00, 01/06/2003-10/31/2003)
FOREST LABORATORIES, INC./PROTOCOL #ANC-MD-17 ($57,740.00, 01/06/2003-10/31/2003)
SCHERING-PLOUGH - PROTOCOL #P00340-72 ($1,000.00, 07/14/2000-07/13/2003)
SCHERING-PLOUGH - PROTOCOL #P00340-72 ($3,000.00, 07/14/2000-07/13/2003)
JOY MCCANN CULVERHOUSE ENDOWED CHAIR IN ALLERGY AND IMMUNOLOGY ($684,692.00, 07/01/2002-06/30/2003)
JOY MCCANN CULVERHOUSE ENDOWED CHAIR IN ALLERGY AND IMMUNOLOGY ($494,816.00, 07/01/2002-06/30/2003)
BAXTER HEALTHCARE CORPORATION PROTOCOL # 309801 ($105,000.00, 06/15/2000-06/15/2003)
OTSUKA MARYLAND RESEARCH INST./PROTOCOL #197-01-210 ($4,000.00, 01/28/2002-04/09/2003)
OTSUKA MARYLAND RESEARCH INST./PROTOCOL #197-01-210 ($10,000.00, 01/28/2002-04/09/2003)
OTSUKA MARYLAND RESEARCH INST./PROTOCOL #197-01-210 ($15,600.00, 01/28/2002-04/09/2003)
OTSUKA MARYLAND RESEARCH INST./PROTOCOL #197-01-210 ($2,500.00, 01/28/2002-04/09/2003)
OTSUKA MARYLAND RESEARCH INST./PROTOCOL #197-01-210 ($65,802.00, 01/28/2002-04/09/2003)
PHARMACEUTICAL RESEARCH ASSOC./SMITHKLINE BEECHAM/PROTOCOL #SAS 40037 ($2,000.00, 12/12/2001-04/01/2003)
PHARMACEUTICAL RESEARCH ASSOC./SMITHKLINE BEECHAM/PROTOCOL #SAS 40037 ($8,000.00, 12/12/2001-04/01/2003)
PHARMACEUTICAL RESEARCH ASSOC./SMITHKLINE BEECHAM/PROTOCOL #SAS 40037 ($47,200.00, 12/12/2001-04/01/2003)
PHARMACEUTICAL RESEARCH ASSOC./SMITHKLINE BEECHAM/PROTOCOL #SAS 40037 ($3,000.00, 12/12/2001-04/01/2003)
MERCK & CO. PROTOCOL #120-00 ($6,487.00, 02/03/2000-02/02/2003)
PROTOCOL # ANC-MD-07-000 ($2,920.00, 01/01/2000-12/31/2002)
GLAXOSMITHKLINE/PROTOCOL # SMS40321 ($33,000.00, 11/28/2001-11/30/2002)
FOREST LABORATORIES/PROTOCOL #ANC-MD-09 ($4,500.00, 01/01/2001-09/01/2002)
FOREST LABORATORIES/PROTOCOL #ANC-MD-09 ($1,000.00, 01/01/2001-09/01/2002)
CLINICAL TRIALS/GLAXO WELLCOME PROTOCOL SMS40314 ($96,608.00, 06/30/2001-08/31/2002)
CLINICAL TRIALS/GLAXO WELLCOME PROTOCOL SMS40314 ($111,014.00, 06/30/2001-08/31/2002)
THE EFFICACY OF DISODIUM OCTABORATE TETRAHYDRATE (DOT) AND VACUUM CLEANING IN LOWERING HOUSE DUST MITE POPULATION AND HOUSE DUST MITE ALLERGEN LEVELS IN HOMES IN TAMPA, FLORIDA ($7,757.00, 08/01/2000-07/01/2002)
EFFECTIVENESS OF LOW DOSE THEOPHYLLINE AS ADD-ON THERAPY IN THE TREATMENT OF ASTHMA (THE LODO TRIAL) ($4,000.00, 10/01/2001-06/30/2002)
ASSOCIATION OF GENETIC MARKERS WITH ASTHMA ($179,743.00, 07/01/1999-06/30/2002)
PROTOCOL # P00221-07 ($4,160.00, 06/28/1999-06/27/2002)
PARIETARIA FLORIDANA AND ALLERGIC RHINITIS IN THE TAMPA BAY AREA ($8,000.00, 12/06/2000-05/31/2002)
VIROPHARMA/PROTOCOL #843-061 ($21,748.00, 09/24/2001-03/31/2002)
VIROPHARMA/PROTOCOL #843-059 ($21,748.00, 09/24/2001-03/31/2002)
ASTRA ZENECA/PROTOCOL #268 ($1,500.00, 04/01/2001-03/31/2002)
ASTRA ZENECA/PROTOCOL # 301 ($1,500.00, 03/01/2001-02/28/2002)
ASTRA ZENECA/PROTOCOL #302 ($1,500.00, 03/01/2001-02/28/2002)
GLAXO WELLCOME PROTOCOL FDP 40012 ($18,100.00, 10/04/2000-12/31/2001)
GLAXO WELLCOME PROTOCOL FDP 40012 ($32,600.00, 10/04/2000-12/31/2001)
SCHERING-PLOUGH RESEARCH/PROTOCOL #P0198-12 ($58,875.00, 12/15/2000-12/15/2001)
SIIVA ($29,743.00, 01/01/2000-12/01/2001)
FOREST LABORATORIES/PROTOCOL #ANC-MD-09 ($43,075.00, 01/01/2001-10/01/2001)
PROTOCOL # BAY 19-8004/100245 ($75.00, 02/15/2000-08/31/2001)
PROTOCOL # SFCA 3006 ($6,444.00, 08/12/1998-08/11/2001)
THE EFFICACY OF DISODIUM OCTABORATE TETRAHYDRATE (DOT) AND VACUUM CLEANING IN LOWERING HOUSE DUST MITE POPULATION AND HOUSE DUST MITE ALLERGEN LEVELS IN HOMES IN TAMPA, FLORIDA ($89,658.00, 08/01/2000-07/01/2001)
CLINICAL TRIALS/GLAXO WELLCOME PROTOCOL SMS40314 ($45,800.00, 10/05/2000-06/30/2001)
CLINICAL TRIALS/GLAXO WELLCOME PROTOCOL SMS40314 ($7,200.00, 10/05/2000-06/30/2001)
RHINITIS IN PATIENTS WITH GASTROESOPHAGEAL REFLUX: PREVALANCE AND CHARACTERIZATION ($5,404.00, 07/01/2000-06/30/2001)
SCHERING-PLOUGH PROTOCOL # P00736-19 ($2,500.00, 01/25/2001-02/25/2001)
INTEGRATED THERAPEUTICS/PROTOCOL # P01556 ($1,000.00, 05/23/2000-12/31/2000)
MERCK & CO., INC./PROTOCOL #119-00 ($1,500.00, 10/22/1999-10/21/2000)
PROTOCOL # 9188IL/0155 ($95,440.00, 02/01/1999-10/01/2000)
MERCK & CO. INC. PROTOCOL # 116-02 ($1,500.00, 09/15/1999-09/15/2000)

Lectures

"A Therapeutic Option for Patients with Asthma" 343. Merck Speaker Program. FL, United States - 2011.
"Heterogeneity in Asthma" 342. Merck Speaker Program. FL, United States - 2010.
"Expanding Treatment Options for Patients with Asthma" 340. Merck Speaker Program. FL, United States - 2010.
"Differential Diagnosis and the Treatment of COPD" AstraZeneca Speaker Program. FL, United States - 2010.
"Defining Phenotypes: Expanding our Understanding of Asthma" Association of Asthma Educators 2010 conference. FL, United States - 2010.
"Is My Immune System Working Correctly?" Informative Health Presentations, Tampa General Hospital and University Village Retirement Center. FL, United States - 2010.
"Risk Assessment, Anaphylaxis, Use of Epinephrine" 336. USF Pediatric Grand Rounds. FL, United States - 2010.
"Anaphylaxis Update: Risk Assessment and Use of Epinephrine" , Louisiana Society of Allegy, Asthma & Immunology (LSAAI) 37th Annual Scientific Meeting. LA, United States - 2010.
"NHLBI Phenotypes of Asthma" , Louisiana Society of Allegy, Asthma & Immunology (LSAAI) 37th Annual Scientific Meeting. LA, United States - 2010.
"Asthma and Comorbid Conditions: The Role of the Allergist" Broward Palm Beach Allergy Society. FL, United States - 2010.
"Hereditary Angioedema" Broward Palm Beach Allergy Society. FL, United States - 2010.
"Asthma and Comorbid Conditions" , Pediatric Grand Rounds, West Virginia University School of Medicine. PA, United States - 2010.
"Treatment of anaphylaxis" World Allergy Organization (WAO) International Scientific Conference (WISC). UAE - 2010.
"Asthma, GERD and laryngeal pharyngeal reflux (LPR)" World Allergy Organization (WAO) International Scientific Conference (WISC). UAE - 2010.
"Asthma and comorbid conditions" World Allergy Organization (WAO) International Scientific Conference (WISC). UAE - 2010.
"NHLBI: Asthma phenotypes" World Allergy Organization (WAO) International Scientific Conference (WISC). UAE - 2010.
"When and how to use epinephrine / Treatment of anaphylaxis" World Allergy Organization (WAO) International Scientific Conference (WISC). UAE - 2010.
"Role of bone scanning in asthma and osteoporosis" World Allergy Organization (WAO) International Scientific Conference (WISC). UAE - 2010.
"Subcutaneous immunotherapy: does it still exist" XVI Latin American Congress of Allergy, Asthma and Immunology, XXXVII Brazilian Congress of Allergy and Immunopatholgoy and CONASMA 2010 . Brazil - 2010.
"Anaphylaxis" XVI Latin American Congress of Allergy, Asthma and Immunology, XXXVII Brazilian Congress of Allergy and Immunopatholgoy and CONASMA 2010 . Brazil - 2010.
"Recent Advances in Insect Allergy" XVIII National Congress of Allergy, Asthma & Pediatric Immunology. Mexico - 2010.
"Adverse Effects and Fatalities Associated with Subcutaneous Allergen Immunotherapy" XVIII National Congress of Allergy, Asthma & Pediatric Immunology. Mexico - 2010.
"Gastroesophageal Reflux and Asthma, Does One Exacerbate the Other?" National Congress of Allergy, Asthma & Pediatric Immunology. Mexico - 2010.
"Mixing allergens: Why and when " 86. 29th Congress of the European Academy of Allergy and Clinical Immunology (EAACI). United Kingdom - 2010.
"Asthma and comorbid conditions" 85. Symposium: Adverse Reactions to Bovine Proteins a Presentation of the World Allergy Organisation (WAO) Guidelines: Diagnosis and Rationale for Action against Cows Milk Allergy (DRACMA), . Italy - 2010.
"GERD and Asthma" XIX World Congress of Asthma. France - 2009.
"The new NIH asthma guidelines" 7th International Congress of the Egyptian Society of Pediatric Allergy & Immunology. Egypt - 2009.
"Anaphylaxis and Allergies" Hispanic American Allergy, Asthma & Immunology Association. DC, United States - 2009.
"Immunotherapy: the American Way" XXVIII Congress of the European Academy of Allergology and Clinical Immunology. Poland - 2009.
"Update on Insect Allergy" Portuguese Society of Allergology and Clinical Immunology (SPAIC). Portugal - 2009.
"Debate, The Ring of Pro & Con Pro: Is Multiple Allergen Immunotherapy Effective?" European Academy of Allergology and Clinical Immunology (EAACI). Spain - 2008.
"Angioedema" XXII Allergy Course . Brazil - 2007.
"GERD and Asthma" XXII Allergy Course . Brazil - 2007.
"Asthma, COPD and Osteoporosis" XXII Allergy Course . Brazil - 2007.
"Inhibition of RSV induced inflammation using siRNA technique" Korean Academy of Asthma, Allergy and Clinical Immunology. South Korea - 2006.
"The Diagnosis of IgE Sensitization" American College of Allergy, Asthma and Immunology. Greece - 2006.
"The Symptoms and Treatment of Asthma" American College of Allergy, Asthma and Immunology. Greece - 2006.
"GERD and Asthma" XIV Latin-American Congress of Allergy, Asthma and Immunology. Argentina - 2006.
"Subcutaneous Immunotherapy: Efficacy and Safety" XIV Latin-American Congress of Allergy, Asthma and Immunology. Argentina - 2006.
"What is New in the Pathogenesis and Treatment of Asthma" International Symposium of Allergies in Otolaryngology and Asthma. , United States - 2006.
"Mechanisms of Anaphylaxis" XXV EAACI Congress. Austria - 2006.
"Insect Allergy" XIV Latin-American Congress of Allergy, Asthma and Immunology. Argentina - 2006.
"Anaphylaxis: Basic Mechanism and Clinical Spectrum" XIV Latin-American Congress of Allergy, Asthma and Immunology. Argentina - 2006.
"Allergen Extracts: Standardization and Efficacy" XIII National Congress of Allergy, Asthma & Pediatric Immunology. Mexico - 2005.
"Allergy Emergency: Anaphylaxis" XIII National Congress of Allergy, Asthma & Pediatric Immunology. Mexico - 2005.
"Sublingual vs. subcutaneous immunotherapy- Which is better?" World Allergy Congress. Germany - 2005.
"How do we manage immunotherapy in asthma" World Allergy Congress. Germany - 2005.
"New concepts in anaphylaxis" World Allergy Congress. Germany - 2005.

Profile last modified on 10/28/2009